Clinical Trial Update: Efficacy and Safety Study of MT10109L in the Treatment of Glabella Line(Including a Preliminary Study to Evaluate Safety of MT10109L) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating MT10109L for efficacy and safety in treating glabella line severity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabella Line Severity

Drugs mentioned

• MT10109L

Snippet

Sponsor: Medy-Tox | Conditions: Glabella Line Severity | Phase 2, Phase 3 | Status: COMPLETED